A next-generation biomarker quantification platform built to meet the precision and efficiency demands of modern pathology research.
MedMorphIQ offers an end-to-end workflow for biomarker quantification, combining intelligent auto-counting with expert-guided review for reproducible, research-grade reliability. Its outputs, cleanly formatted PDF and PNG reports, are optimized for integration into existing pathology systems, enabling rapid turnaround without disrupting established protocols.
MedMorphIQ quantifies the full breast IHC panel, Ki-67, ER, PR, and HER2, directly from standard microscope fields of view, with no whole-slide scanner required. The platform is built to scale across additional biomarkers and histopathological applications spanning a wide range of cancer types.
Drop in a raw pathology image, no special formatting required.
AI detects and quantifies staining across Ki-67, ER, PR, and HER2.
Expert-guided review keeps every result reproducible and reliable.
Export publication-ready PDF & PNG reports, workflow-integrated.
MedMorphIQ’s AI seamlessly transforms raw pathology images into actionable, expert-level results, see the process side by side.

